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ABSTRACTS S275Introduction: NICE clinical guideline development includes a review
of available data on UK clinical practice with regard to the management of
the disease under consideration. The purpose is to identify concerning vari-
ability or areas of controversy, and set the scene for focused guideline
recommendations.
Aims: To assess the availability and quality of current clinical practice
data on aspects of colorectal cancer management for the purpose of the
recently developed NICE colorectal cancer clinical guideline.
Methods: Methods include online data mining, national database
queries, and the observation of the NICE guideline development process
through both membership of the guideline development group established
to produce the recommendations, and the technical development team sup-
porting its production.
Results: Results show that data regarding current clinical practice on
colorectal cancer collected by national databases has methodological chal-
lenges and is not easily accessible. Despite encouraging initial assessment
of feasibility, the lack of a timely result from the national databases as ac-
cessed through the lead cancer registry for colorectal cancer is disap-
pointing, and it is an important finding in itself.
Conclusion: In conclusion, there is a responsibility to patients to
ensure their data, which is routinely collected and stored, is appropriately
accessible for research and aids the provision of answers to important clin-
ical questions that could help improve their overall management. At pre-
sent there is a huge expansion in national database systems. Funding,
human resources and technical support are being diverted to this chroni-
cally neglected field of health management and this is a welcome improve-
ment.
http://dx.doi.org/10.1016/j.ejso.2015.08.126
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Rationale: Several recent studies have shown that a delay in radical
therapy by over 12 weeks from the diagnosis of a muscle invasive bladder
cancer can worsen prognosis.
Aim: To identify at which points in the patient pathway delays occur
from the time of diagnosis to radical therapy.
Methods: This study retrospectively audited two groups of patients; 25
consecutive patients undergoing either radical cystectomy or cystoprosta-
tectomy over a 12-month period; and 25 consecutive patients receiving
radical radiotherapy over a 48month period. From these two groups a third
group was made for patients who received neo-adjuvant chemotherapy.
The time at which these patients received their first course of chemo-
therapy was taken as the date of radical therapy. Two patients were
excluded due to incomplete data available. Data was collected from clinic
letters and clinical notes.
Results: Of the 48 patients studied the median time from TURBT to
receiving histological diagnosis of bladder cancer was 6 (4e9.25) days
(median (IQR)). The time from TURBT to being reviewed in MDT was
a median of 15 (9e18) days. Of the patient population 33% were seen
in clinic post MDT solely by a surgeon, 23% solely by an oncologist,
13% in a joint uro-oncology clinic and 31% by both a surgeon and oncol-
ogist but in separate clinics. The time taken from MDT to radical therapy
was a median of 51 (46e69) days for the surgical group; 32 (28e40) days
XRT group; and 34.5 (30e45) days for the neo-adjuvant chemotherapy
group. Subsequently the total time taken to treat with radical therapy
from TURBT was 66 days for the surgical group, 47 days XRT group,
and 49.5 days for neo-adjuvant chemotherapy.Conclusions: The time taken to treat in this centre was within the stan-
dards suggested in the literature. However it was felt that this could be
improved following identifying delays in the referral process to MDT
and waiting times once listed for surgery.
http://dx.doi.org/10.1016/j.ejso.2015.08.127
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Introduction: Defunctioning loop ileostomy has been used to divert
faecal stream to protect low rectal anastomosis and to reduce the conse-
quences of anastomotic leak following open as well as laparoscopic low
anterior resection surgery. The majority of colorectal surgeons consider
this easy to perform and associated with low morbidity. However, the for-
mation and the reversal of loop ileostomies are underrated operations and
are associated with considerable morbidity and mortality.
Methods: We have evaluated our practice in formation of defunction-
ing loop ileostomy in colorectal surgery by measuring the number of com-
plications associated with defunctioning loop ileostomy. A retrospective
analysis of prospectively collected data on all patients who had diversion
loop ileostomy either as a ‘primary’ procedure or as a ‘secondary’ proce-
dure as part of major low rectal anastomosis surgery was performed at our
institution over a 5 year period; a total of 255 patients. Patient’s data
related to age, diagnosis, type of surgery, length of stay, stoma reversal,
pre and post-surgery urea and electrolytes’ measurements and stoma com-
plications were collected and data were analysed.
Results: There was a complication rate of 27.6%, with obstruction,
parastomal hernias, high stomal output, and procedure related complica-
tions being the most common occurring complications.
Conclusion: This study has demonstrated that formation and reversal
of loop ileostomy is associated with considerable morbidity following sur-
gery and a decision to perform a loop ileostomy needs to be balanced
against the risks of anastomotic leakage. While defunctioning loop colos-
tomy is considered more difficult to manage, the authors believe that it
might be associated with less morbidity. A call for a randomised controlled
trial is suggested to help answering this question.
http://dx.doi.org/10.1016/j.ejso.2015.08.128
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Introduction: Axillary nodal clearance (ANC) remains standard ther-
apy in sentinel lymph node (SLN) positive patients. A high rate of negative
non-SLN (nSLN) and low axillary recurrence rates have prompted a more
conservative approach. We have assessed patients having ANC to see
where this might have been safely avoided in SLN positive axillae.
Methods: Patients having ANC after positive SLNB between Feb
2013-Jun 2015 were analysed retrospectively.
S276 ABSTRACTSResults: 89 patients had ANC & 1 was excluded, N¼ 88 (WLE
n¼ 45, mastectomy n¼ 43).
Number of Mastectomy Patients with WLE Patients withpositive sentinel
nodesgroup
(n¼ 43)
further nSLN
(%)group
(n¼ 45)
f
(urther nSLN
%)Micrometastasis 6 3 (50) 7 1 (14.2)1 21 12 (57.1) 29 5 (17.2)2 12 10 (83.3) 8 4 (50)3 3 3 (100) 1 0 (0)4 1 1 (100)In the mastectomy group, 39/43 (90.6%) had <2 SLN involved. Of
these 39, 25 (64.1%) had further positive axillary lymph nodes on ANC.
In contrast, the WLE group had only 10 patients (22.7%) with further pos-
itive axillary lymph nodes on ANC. In the mastectomy group, 14/44 pa-
tients had more than 3 nodes involved in ANC. This information would
have been missed if ANC had not been carried out.
Discussion: For patients having mastectomy, the axilla should be
treated in SLN positive patients because of the high burden of positive
nSLN. However, ANC could be foregone in WLE patients with 1 or 2 pos-
itive SLNs.
Conclusion: Some patients can avoid ANC after positive SLN.
http://dx.doi.org/10.1016/j.ejso.2015.08.129
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Introduction: Acceptable microscopic margin width following breast
conserving surgery varies between breast units. Recently in the US,
consensus guidelines have stated that there is no evidence to support a sig-
nificant difference in recurrence rates between margins with no ink or mar-
gins  1 mm. We sought to determine whether re-excisions following wide
local excision have residual disease.
Methods: Wire-guided WLE for DCIS or invasive disease between
July 2013 and December 2014 were identified. The presence of residual
disease was determined in the re-excision specimens. Our unit re-excises
with involved or close margins (DCIS  2 mm and invasive disease 
1 mm).
Results: 198 WLE were performed. Of these, 50 underwent re-exci-
sions with 30% containing residual disease. With DCIS, 23 underwent
re-excision with residual disease found in 7 specimens, 6 of which had
involved margins at the original surgery. Similarly, in invasive disease,
of 27 re-excisions, residual disease was present in 8 specimens, of which
5 had had involved and 3 close margins.
Conclusion: With further disease found in the re-excision specimen
73% had an involved margin at original surgery. We suggest that it is
less likely for there to be residual disease with clear margins and radio-
therapy may be sufficient, avoiding the morbidity of re-excision.
http://dx.doi.org/10.1016/j.ejso.2015.08.130
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Background: Lipofilling is a reconstructive and aesthetic technique
that has recently grown in popularity and is increasingly being used inbreast surgery. Concerns have been raised regarding its safety when used
for remodelling and reconstruction of the breast.
Methods:We reviewed the current literature by systematically searching
PubMed and Google Scholar databases regarding the current evidence
regarding the oncological safety of the procedure in patients seeking aesthetic
breast enhancement and in patients requiring oncoplastic reconstruction.
Results: Among the 864 patients included in the currently available
studies on breast cancer patientswho underwent lipofilling, only 14 (1.6%) re-
currences were identified. However, evidence has emerged regarding the use
of lipofilling in the background of ductal carcinoma in situ (DCIS).
Conclusions: Over the subsequent two decades, little evidence has
been found to support these early theoretical concerns, and growing
numbers of proponents of the procedure are confident in its safety. Further
study is required to better delineate the effect of lipofilling on DCIS.
http://dx.doi.org/10.1016/j.ejso.2015.08.131
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Introduction: 1/3 of women with early breast cancer are treated with
mastectomy. There are concerns about over treatment and marked regional
variations in procedures. Our breast unit protocal is to perform a mastec-
tomy in patients with breast cancer if the disease is; multicentric Ductal
Carcinoma in Situ (DCIS), extensive DCIS>4 cm unless breast size will
permit an attempted breast conserving surgery (BCS), multicentric Inva-
sive carcinoma, margins<2 mm when re-excision is not possible, recur-
rence and patient choice.
Aim: To investigate the mastectomy-making decision process and re-
view adherence to local guidelines.
Methods: A retrospective study at Medway Hospital between 01/01/
2014-30/12/2014 of breast cancer patients undergoing mastectomy. Data
collection included clinic letters, radiology, MDMdiscussions and pathology.
Results: 277 patients with breast cancer required surgical treatment. 84
patients had mastectomy (31%). The mean age was 67 years (43e94). 80
patients had a mastectomy as a primary procedure after initial diagnosis of
breast cancer. The most common indications for primary mastectomy
were; Large Tumour>4 cm (21%), multicentric tumour (17%) and recur-
rence (12%). Other indications were; patient choice(11%), skin involve-
ment, location, local control(10%), tumour distorting the areola-nipple
complex(7%), extensive microcalcification(5%), patient mobility prob-
lems(5%), large central tumour(4%), tumour in small breasts(3%) and
large multifocal tumour(1%). Four patients had a mastectomy as a comple-
tion procedure after having BCS.
Conclusion: Tumour size, multicentric and recurrence of tumour were
the main criteria for mastectomy making decisions. BCS margin resection
involvement is the main indication for completion mastectomy. The
criteria for mastectomy have not changed. The rate of mastectomy has re-
mained similar despite early diagnosis of breast cancer in the recent years.
http://dx.doi.org/10.1016/j.ejso.2015.08.132
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Introduction: Incidence of malignant melanoma is predicted to rise by
15% in 15years. There are survival variations between cancer networks.
